Mark Wefers Bettink

Mitochondrial oxygen monitoring during surgical repair of congenital diaphragmatic hernia or esophageal atresia: 9 179 15. Ubbink R, Bettink MAW, Janse R, Harms FA, Johannes T, Munker FM, Mik EG. A monitor for Cellular Oxygen METabolism (COMET): monitoring tissue oxygenation at the mitochondrial level. J Clin Monit Comput (2017) 31 :1143–1150. doi:10.1007/s10877-016-9966-x10.1007/s10877- 016-9966-x [pii] 16. Baumbach P, Neu C, Derlien S, Bauer M, Nisser M, Buder A, Coldewey SM. A pilot study of exercise-induced changes in mitochondrial oxygen metabolism measured by a cellular oxygen metabolism monitor (PICOMET). Biochim Biophys Acta - Mol Basis Dis (2019) 1865 :749-758 doi:10.1016/j.bbadis.2018.12.003 17. Mik EG. Special article: measuring mitochondrial oxygen tension: from basic principles to application in humans. Anesth Analg (2013) 117 :834–846. doi:ANE.0b013e31828f29da [pii]10.1213/ANE.0b013e31828f29da 18. Mik EG, Stap J, Sinaasappel M, Beek JF, Aten JA, van Leeuwen TG, Ince C. Mitochondrial PO2measured by delayed fluorescence of endogenous protoporphyrin IX. Nat Methods (2006) 3 :939-945 doi:10.1038/nmeth940 19. Eber AE, Perper M, Verne SH, Magno R, ALOmair IAO, ALHarbi M, Nouri K. “Photodynamic therapy,” in Lasers in dermatology and medicine: dermatologic applications (2018) 261-273 doi:10.1007/978-3-319-76118-3_16 20. Blume JE, Oseroff AR. Aminolevulinic Acid Photodynamic Therapy for Skin Cancers. Dermatol Clin (2007) 25 :5-14 doi:10.1016/j.det.2006.09.005 21. Hadjipanayis CG, Stummer W. 5-ALA and FDA approval for glioma surgery. J Neurooncol (2019) 141 :479-486 doi:10.1007/s11060-019-03098-y 22. Ferraro N, Barbarite E, Albert TR, Berchmans E, Shah AH, Bregy A, Ivan ME, Brown T, Komotar RJ. The role of 5-aminolevulinic acid in brain tumor surgery: a systematic review. Neurosurg Rev (2016) 39 :545-55 doi:10.1007/s10143-015-0695-2 23. Kumar N, Warren CB. Photodynamic therapy for dermatologic conditions in the pediatric population: a literature review. Photodermatol Photoimmunol Photomed (2017) 33 :125-134 doi:10.1111/phpp.12296 24. C. Burford, N. Thamenah Kalyal, A. Pandit, J. Tailor, J. Pedro Lavrador, A. Bravo, A. Kugisaki, S. Bassi, C. Chandler, S. Zacharoulis BZ. The UK’s first case series of 5-aminolevulinic acid use in paediatric brain tumours. EANS Acad (2016) 19 : i11, Available at: https://academy.eans.org/ eans/2016/athens/140544/nida.thamenah.kalyal.the.uks.first.case.series.of.5-aminolevulinic. acid.use.in.html 25. Stummer W, Rodrigues F, Schucht P, Preuss M, Wiewrodt D, Nestler U, Stein M, Artero JMC, Platania N, Skjøth-Rasmussen J, et al. Predicting the “usefulness” of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey. Acta Neurochir (Wien) (2014) 156 :2315–2324 doi:10.1007/s00701-014-2234-2 26. Beez T, Sarikaya-Seiwert S, Steiger HJ, Hänggi D. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of brain tumors in children - a technical report. Acta Neurochir (Wien) (2014) 156 :597-604 doi:10.1007/s00701-014-1997-9 27. Wulf HC, Philipsen P. Allergic contact dermatitis to 5-aminolaevulinic acid methylester but not to 5-aminolaevulinic acid after photodynamic therapy. Br J Dermatol (2004) 150 :143-145 doi:10.1111/j.1365-2133.2004.05723.x 28. SAMENVATTING VAN DE PRODUCTKENMERKEN. Available at: https://db.cbg-meb.nl/smpc/ h113539_smpc.pdf